CHMP3 Activators
CHMP3, also known as Charged Multivesicular Body Protein 3, is a component of the endosomal sorting complex required for transport-III (ESCRT-III). CHMP3 activators encompass a range of chemical compounds that indirectly facilitate the functional activity of CHMP3 through various intracellular signaling pathways and membrane trafficking processes. These activators are not direct agonists in the classical sense but exert their influence on the pathways that CHMP3 is inherently a part of, often leading to the enhanced assembly and disassembly dynamics of the ESCRT-III complex. For instance, certain phospholipids and their analogs can modulate the membrane curvature and lipid composition, which is crucial for the membrane scission events that CHMP3 is involved in. These compounds, by altering the lipid environment, can enhance the propensity for CHMP3 to participate in the formation of multivesicular bodies (MVBs), thus indirectly supporting its role in membrane trafficking.
Moreover, small molecules that influence the ATPase activity of VPS4, which is essential for disassembling the ESCRT-III complex, indirectly impact CHMP3's function. By modulating the availability or efficiency of VPS4, these activators can indirectly enhance CHMP3's role in ESCRT-III mediated processes, such as the final stages of cytokinesis and the budding of certain enveloped viruses. Additionally, compounds that alter the ionic environment within the cell can affect the electrostatic interactions necessary for CHMP3 polymerization and stability, thereby facilitating its assembly into functional complexes. Collectively, CHMP3 activators work through these nuanced mechanistic pathways to support the protein's essential role in cellular homeostasis, specifically in the trafficking of vesicles and the sorting of ubiquitinated proteins destined for degradation in the lysosome.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to increased production of cyclic AMP (cAMP). Since cAMP serves as a second messenger in various signal transduction pathways, the increase in cAMP can enhance CHMP3 activity as it is involved in endosomal sorting processes that are regulated by cAMP-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). Activated PKC can phosphorylate proteins that are involved in the regulation of CHMP3, thus indirectly enhancing CHMP3's role in endosomal membrane trafficking and vesicle formation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium may activate calcium-dependent protein kinases which can modulate the endosomal sorting complex required for transport (ESCRT), of which CHMP3 is a crucial component, thus potentially enhancing CHMP3 activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates cAMP-dependent pathways. It can enhance CHMP3 function by mimicking the action of cAMP and thereby activating pathways that modulate endosomal sorting and membrane trafficking. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) activates S1P receptors, which can lead to the activation of signaling cascades that intersect with CHMP3's role in endosomal trafficking, potentially enhancing CHMP3's functional activity in this process. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain kinases, potentially reducing competitive signal transduction events that could otherwise limit CHMP3 function. This indirect effect could enhance CHMP3's role in vesicle trafficking and endosome dynamics. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters AKT signaling. By modulating this pathway, LY294002 can affect downstream processes that involve CHMP3, such as membrane budding and vesicle formation in the endosomal sorting complex. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide uncouples oxidative phosphorylation, which can lead to alterations in cellular energy states and thus influence the activity of ATP-dependent processes. CHMP3, being part of the ESCRT-III complex, might have its function in membrane remodeling enhanced under such conditions due to adaptive cellular responses. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium. The resultant activation of calcium-dependent signaling pathways can indirectly enhance CHMP3's involvement in membrane trafficking and vesicle scission. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a sodium ionophore that disrupts intracellular ion gradients. This disruption can indirectly enhance CHMP3 function by affecting ion-sensitive signaling pathways and membrane trafficking processes in which CHMP3 is involved. | ||||||